{
    "nctId": "NCT00429572",
    "briefTitle": "Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer",
    "officialTitle": "Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 19,
    "primaryOutcomeMeasure": "Number of Participants With Tumor Response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Recurrent or residual metastatic breast carcinoma\n* Zubrod performance status less than 2\n* 18-60 years old\n* Related donor human leukocyte antigen (HLA)-compatible for allogeneic transplantation or unrelated HLA-compatible donor.\n* No major organ dysfunction or active infection\n\nExclusion Criteria: None",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}